Take 4 capsules in the morning before food and drink at least 2 litres of water through the day.
You can also open the capsules into a glass of water, stir until dissolved and then drink.
Pectasol is scientifically proven to eliminate from deep inside our cells and organs heavy metals such as lead, cadmium, mercury, aluminium, mycotoxins (Toxins from moulds), insecticides, pesticides, chemicals and many other toxic chemicals.
Pectasol is a natural product derived from the pith of citrus fruits, including lemon, and modified using a proprietary enzymatic and PH process. This process guarantees that pectasol has the correct molecular size to cross the cellular barrier and bind toxins which are then eliminated from the body.
WHAT DOES PECTASOL TREAT?
Heart Diseases
High Blood Pressure
Kidney Diseases
Autoimmune diseases such as Multiple Sclerosis
Hormonal imbalances
SCIENTIFIC STUDIES BEHIND PECTASOL
A pilot trial evaluating MCP’s chelating effects provided evidence that orally administered MCP significantly increases urinary excretion of toxic metals. In a study published in 2006, eight healthy individuals were given 15 grams of MCP daily for five days and 20 grams of MCP on day six. Twenty-four-hour urine samples were collected on days one and six and analysed for toxic and essential elements.
The investigators reported that significant urinary excretion of arsenic, mercury, cadmium, and lead increased within one to six days of MCP treatment. There was a 150% increase in the excretion of cadmium and a 560% increase in lead excretion on day six. Essential minerals such as calcium, zinc, and magnesium were not seen to increase in the urine analysis, indicating that MCP treatment did not deplete these nutrients.
In another study, Eliaz, Hotchkiss, Fishman and Rode took five patients with different illnesses and gave them MCP (PectaSol) alone or as an MCP/alginate combination (PectaSol Chelation Complex) for up to seven months. Each saw a gradual decrease in total heavy metal burden, which is believed to have played an important role in the patients’ recovery and health maintenance. The patients had a 74% average decrease in toxic heavy metals after treatment.
The authors report this is the “first known documentation of evidence” of a possible correlation of positive clinical outcomes and a reduction of toxic heavy metal load using MCP alone or as an MCP/alginate complex. They recommend “further studies be performed to confirm the effectiveness of this gentle non-toxic chelating system as an alternative to harsher chelators in the treatment of patients with a heavy metal body burden.”
